A serotype-independent, broad spectrum pneumococcal vaccine [ 2018 - ]

Research Grant

Researchers: Prof James Paton (Principal investigator) ,  Dr Mohammed Alsharifi ,  Prof Timothy Hirst

Brief description Streptococcus pneumoniae (the pneumococcus) is the world’s most formidable bacterial pathogen, causing 1-2 million deaths each year. Existing vaccines provide protection against only a limited proportion of strains and their widespread use is increasing the prevalence of strains against which the vaccines provide no protection. This project aims to translate a novel broadly protective pneumococcal vaccine into the commercial development pipeline.

Funding Amount $955,585.00

Funding Scheme Development Grants

Notes Development Grant